Skip to main content
Fig. 5 | Cancer Nanotechnology

Fig. 5

From: Doxorubicin-loaded polymeric nanoparticles containing ketoester-based block and cholesterol moiety as specific vehicles to fight estrogen-dependent breast cancer

Fig. 5

Biocompatibility of the empty and DOX-loaded polymeric nanoparticles against representatives for normal cells. Hemolytic activity (A) and cell viability study on monocytic cells and cardiomyocyte cells after addition of bare and DOX-loaded polymeric nanoparticles (B and D) and DOX in free form (C and E). Statistical significance for the polymeric nanoparticles without or with DOX or DOX at free form vs. control was marked with (*); comparison of DOX (0.5 µM) at free vs encapsulated form PNP-DOX marked with (^) comparison of PNP vs PNP-DOX marked with (&), concentrations dependent response for PNP-DOX marked with (#), p ≤ 0.05. The data presented constitute average results from three measurements ± SD

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us